PMID- 10711715 OWN - NLM STAT- MEDLINE DCOM- 20000315 LR - 20220408 IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 41 IP - 3 DP - 2000 Mar TI - Neurotrophic factors cause activation of intracellular signaling pathways in Muller cells and other cells of the inner retina, but not photoreceptors. PG - 927-36 AB - PURPOSE: Intravitreal injection of brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (FGF2) promotes survival of photoreceptors exposed to various types of insults, but it is not known if these survival-promoting effects occur by direct action of the factors on photoreceptors or indirectly through the activation of other cells. In this study, the authors have sought to address this issue by determining which cells in the retina show evidence of activated intracellular signaling pathways acutely and at longer time points after intravitreal injection of these agents. METHODS: Retinas were removed from C57BL/6J mice at 1, 6, or 24 hours after intravitreal injection of 1 microg of human BDNF, rat CNTF, human FGF2, or human transforming growth factor-alpha (TGFalpha), and immunohistochemically stained for phosphorylated extracellular signal-regulated kinase (pERK), phosphorylated cAMP responsive element binding protein (pCREB), or c-fos. Retinal organ cultures were incubated with 10 ng/ml of BDNF, CNTF, FGF2, or TGFalpha for 10 or 30 minutes or 1, 3, or 6 hours and then immunohistochemically stained for pERK, pCREB, or c-fos. RESULTS: Intravitreal injection of BDNF, CNTF, or FGF2 resulted in a rapid increase in pERK immunoreactivity in Muller cells and a rapid increase in c-fos immunoreactivity in Muller, amacrine, and ganglion cells. Immunoreactivity for pERK and c-fos returned to baseline in all retinal cells at 6 or 24 hours after injection, but there was increased staining for glial fibrillary acidic protein (GFAP) in Muller cells at these time points. At no time after injection was there any staining for pERK or c-fos in photoreceptors. Similarly, retinal explants treated with FGF2, BDNF, or CNTF showed increased staining for pCREB, pERK, and c-fos in cells of the inner retina, but not photoreceptors. CONCLUSIONS: These data support the hypothesis that BDNF, CNTF, and FGF2 exert their effects on photoreceptors by acting indirectly through activation of Muller cells and perhaps other nonphotoreceptor cells. FAU - Wahlin, K J AU - Wahlin KJ AD - Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. FAU - Campochiaro, P A AU - Campochiaro PA FAU - Zack, D J AU - Zack DJ FAU - Adler, R AU - Adler R LA - eng GR - EY04859/EY/NEI NIH HHS/United States GR - EY05951/EY/NEI NIH HHS/United States GR - EY10017/EY/NEI NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ciliary Neurotrophic Factor) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Glial Fibrillary Acidic Protein) RN - 0 (Proto-Oncogene Proteins c-fos) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Ciliary Neurotrophic Factor/*pharmacology MH - Cyclic AMP Response Element-Binding Protein/metabolism MH - Fibroblast Growth Factor 2/*pharmacology MH - Fluorescent Antibody Technique, Indirect MH - Glial Fibrillary Acidic Protein/metabolism MH - Injections MH - Mice MH - Mice, Inbred C57BL MH - Mitogen-Activated Protein Kinases/metabolism MH - Neuroglia/*drug effects/metabolism MH - Organ Culture Techniques MH - Photoreceptor Cells, Vertebrate/*drug effects MH - Proto-Oncogene Proteins c-fos/metabolism MH - Retinal Ganglion Cells/*drug effects/metabolism MH - Signal Transduction/*drug effects MH - Vitreous Body EDAT- 2000/03/11 09:00 MHDA- 2000/03/18 09:00 CRDT- 2000/03/11 09:00 PHST- 2000/03/11 09:00 [pubmed] PHST- 2000/03/18 09:00 [medline] PHST- 2000/03/11 09:00 [entrez] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2000 Mar;41(3):927-36.